Paula Ragan, Ph.D. is a seasoned leader focused on growing companies and driving innovation with over 25 years of experience in the biotechnology and life sciences industry. She is currently the Managing Director of PMR Advisory LLC, a consulting firm that partners with privately held biotechnology companies to advance their strategic goals. Most recently, Paula founded and served as Chief Executive Officer of X4 Pharmaceuticals, Inc., building the company from inception to a successful initial public offering and advancing its lead asset to FDA approval and U.S. launch as XOLREMDI® (mavorixafor), a first-in-class Breakthrough Therapy for a rare primary immunodeficiency. Before founding X4, Paula served as consulting Chief Business Officer at Lysosomal Therapeutics. Earlier in her career, she spent significant time at Genzyme Corporation, where she held leadership roles in corporate development, manufacturing, and supply chain. Currently, Paula is member of the Board of Advisors for Life Science Cares and a member of the Landmark School Fundraiser Committee. Additionally, Paula serves as a mentor for the Termeer Institute, a non-profit organization cultivating the next generation of biotech leaders. Previously, Paula also served as a Director on the Board of Camp4 Therapeutics. Paula holds a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology (HST), an M.S. in Biomedical Engineering from Boston University, and a B.S. in Mechanical Engineering from Tufts University.